Cargando…
PIK3CA mutations and their response to neoadjuvant treatment in early breast cancer: A systematic review and meta‐analysis
BACKGROUND: PIK3CA mutations frequently occur in breast cancer patients. This study was conducted to evaluate the relationship between PIK3CA mutations and neoadjuvant treatment response and to analyze the clinical implications. METHODS: PubMed, Embase, and the Cochrane database were searched for re...
Autores principales: | Fan, Hongwei, Li, Chao, Xiang, Qian, Xu, Ling, Zhang, Zhuo, Liu, Qianxin, Zhang, Tonttong, Zhou, Ying, Zhao, Xia, Cui, Yimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5928352/ https://www.ncbi.nlm.nih.gov/pubmed/29575819 http://dx.doi.org/10.1111/1759-7714.12618 |
Ejemplares similares
-
KRAS and PIK3CA bi-mutations predict a poor prognosis in colorectal cancer patients: A single-site report
por: Luo, Qianxin, et al.
Publicado: (2020) -
Circulating microRNAs as indicators in the prediction of neoadjuvant chemotherapy response in luminal B breast cancer
por: Zhang, Zhuo, et al.
Publicado: (2021) -
Concomitant PIK3CA and TP53 Mutations in Breast Cancer: An Analysis of Clinicopathologic and Mutational Features, Neoadjuvant Therapeutic Response, and Prognosis
por: Lin, Xiao-Yi, et al.
Publicado: (2023) -
Hematologic side effects of immune checkpoint inhibitor with or without chemotherapy in patients with advanced and metastatic gastrointestinal cancer: A systematic review and network meta-analysis of phase 3 trials
por: Hou, Jingyi, et al.
Publicado: (2023) -
Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
por: Chen, Li, et al.
Publicado: (2018)